LCM
IOVA icon

Laurion Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Laurion Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-637,742
Closed -$5.18M – 594
2023
Q4 		$5.18M Buy
+637,742
New +$3.34M 0.19% 243
2022
Q2 		– Sell
-22,558
Closed -$376K – 598
2022
Q1 		$376K Buy
+22,558
New +$349K 0.01% 408
2020
Q3 		– Sell
-49,495
Closed -$1.36M – 994
2020
Q2 		$1.36M Buy
49,495
+35,895
+264% +$1.18M 0.05% 363
2020
Q1 		$407K Buy
+13,600
New +$360K 0.01% 607

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return